| Nov 20 |
Lexicon Appoints Ivan H. Cheung to Board of Directors
|
| Nov 18 |
Lexicon Pharmaceuticals (NASDAQ:LXRX investor three-year losses grow to 80% as the stock sheds US$107m this past week
|
| Nov 14 |
Post-Hoc Analysis Demonstrating Sotagliflozin Benefits Across Broad Spectrum of Heart Failure Patient Populations is Among Four Lexicon-Supported Presentations at the American Heart Association’s (AHA) Sessions 2024 in Chicago
|
| Nov 13 |
Lexicon Pharmaceuticals Inc (LXRX) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ...
|
| Nov 13 |
Lexicon Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 13 |
Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
Lexicon Pharmaceuticals (LXRX) Reports Q3 Loss, Lags Revenue Estimates
|
| Nov 12 |
Lexicon Pharmaceuticals GAAP EPS of -$0.18 misses by $0.01, revenue of $1.75M misses by $1.18M
|
| Nov 12 |
Lexicon: Q3 Earnings Snapshot
|
| Nov 12 |
Lexicon Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
|
